Followers | 168 |
Posts | 17809 |
Boards Moderated | 3 |
Alias Born | 11/29/2010 |
Monday, February 29, 2016 9:50:22 PM
Also, according to the last filing in 2015, Eugenio Santos is "Chairman of the Board, Chief Executive Officer, Chief Financial Officer, and Director." Disregard OTC's company profile as all officers and directors resigned. Also it states the O/S is 152 million when only >>$50 million are
authorized.<< Financials are >>not audited.<<
Finally.. anyone who likes having a $1.95 investment evaporate to $.0.05 in 2 years then this might just be the one!
My "opinion" is as valid as your "hearsay"
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM